Kamoto, Japan

Katsutoshi Aihara

This inventor holds 1 USPTO granted patent. Top assignee: Chemo-Sero-Therapeutic Research Institute. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsutoshi Aihara. Retrieved from https://idiyas.com/inventor/katsutoshi-aihara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Katsutoshi Aihara

Introduction

Katsutoshi Aihara is a notable inventor based in Kamoto, Japan. He has made significant contributions to the field of medical research, particularly in the development of vaccines. His innovative work has led to the creation of a method that enhances the safety and efficacy of pertussis vaccines.

Latest Patents

Aihara holds a patent for a "Method for preparing pertussis toxin toxoid using HcHo and amino acids." This patent discloses a method for preparing pertussis toxin toxoid by treating pertussis toxin with formaldehyde. The treatment is carried out in the presence of lysine or glycine in combination with N-acetyltriptophan. The resultant toxoid does not exhibit toxicity reversion, making it highly suitable for use in pertussis vaccines. He has 1 patent to his name.

Career Highlights

Katsutoshi Aihara is associated with the Chemo-Sero-Therapeutic Research Institute, where he has been instrumental in advancing vaccine research. His work has been pivotal in improving vaccine formulations, ensuring they are both safe and effective for public health.

Collaborations

Aihara has collaborated with notable colleagues such as Kazunori Morokuma and Akihiro Ginnaga. Their combined expertise has contributed to the success of various research projects and innovations in the field.

Conclusion

Katsutoshi Aihara's contributions to vaccine development through his innovative methods highlight the importance of research in public health. His work continues to influence the field positively, ensuring safer vaccines for future generations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…